Article
Comparative Study of Cabergoline and Hydroxychloroquine to Prevent Ovarian Hyperstimulation Syndrome (OHSS) in PCOS Patients: A Pilot Randomized Clinical Trial
2025-04-17
Abstract excerpt
<title>Abstract</title> <p>Background This study compared the effectiveness of cabergoline and hydroxychloroquine in preventing ovarian hyperstimulation syndrome (OHSS) in patients with polycystic ovary syndrome (PCOS) undergoing controlled ovarian stimulation. Materials and Methods This double-blind, parallel, and randomized clinical trial was performed from April to June 2024. Forty-two patients with PCOS who...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- f797428d-bb9d-5cfb-acae-7f83864d17f7
- DOI
- 10.21203/rs.3.rs-5855263/v1
